Clinical Trials

In the early 1960s, though cannabis had been used for centuries and demonized for decades by governments around the globe, the science world knew surprisingly little about the plant itself. Scientists had long since learned how to synthesize morphine from the opium poppy and cocaine from coca leaves, but what about cannabis? Few in the […]

DEVON, Pa., March 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will present at upcoming investor conferences in March, including: 29th Annual ROTH Conference in Orange County, CA, on […]

LONDON, Nov. 10, 2016 /PRNewswire/ — Bone marrow transplant or hematopoietic stem cell transplant is the surgical procedure to replace impaired bone marrow tissue or bone marrow stem cells with healthy ones. Bone marrow transplant procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, […]

DEVON, Pa., March 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will present at upcoming investor conferences in March, including: 29th Annual ROTH Conference in Orange County, CA, on […]

Shares of INSYS Therapeutics, Inc. (NASDAQ:INSY) dropped -6.02% by the end of trading session at $12.03. For the current quarter, the 4 brokerage firms issuing adjusted earnings per share outlook have a consensus forecast of 0/share, which would compare with $0.36 in the year-ago quarter. The net percentage change is -28.31% over the last 12 […]

by

OTTAWA, ONTARIO–(Marketwired – Feb 23, 2017) – PhytoPain Pharma (PPP), a subsidiary of Tetra BioPharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce the launch of its Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics […]

by

SAN DIEGO, Feb. 6, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment AXIM® Biotechnologies, Inc. (OTC: AXIM) was featured on a CBS New York News segment about the Company’s clinical trials for its CanChew Plus® cannabidiol (CBD) chewing gum for the […]

by

OTTAWA, ONTARIO–(Marketwired – Feb 23, 2017) – PhytoPain Pharma (PPP), a subsidiary of Tetra BioPharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(OTC:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce the launch of its Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics and […]

by

VANCOUVER, British Columbia, Feb. 22, 2017 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSXV:KALY) (“Kalytera”) is pleased to announce encouraging results from a Phase 2a study evaluating the safety and efficacy of cannabidiol (“CBD”), a primary constituent of the marijuana plant, for the treatment of acute (Grade 3-4) Graft versus Host Disease (“GvHD”). In the present […]

by

VANCOUVER, British Columbia, Feb. 22, 2017 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSXV:KALY) (“Kalytera”) is pleased to announce encouraging results from a Phase 2a study evaluating the safety and efficacy of cannabidiol (“CBD”), a primary constituent of the marijuana plant, for the treatment of acute (Grade 3-4) Graft versus Host Disease (“GvHD”). In the present […]

by

Medical marijuana developer Tilray has begun shipping to overseas patients and trial sites outside Canada after partnering with local distributors to comply with regional regulations. Nanaimo-headquartered Tilay announced it will export medical marijuana to patients in Chile, Brazil and New Zealand this week also confirming it has started supplying product candidates to trial sites in […]

by

WASHINGTON — Researchers started this week the first-ever clinical trial of marijuana for treating the effects of post-traumatic stress disorder in veterans. The trial will test four potencies of smoked marijuana and their effects to manage PTSD symptoms in 76 veterans, according to the Multidisciplinary Association for Psychedelic Studies. Approved by the Drug Enforcement Administration […]

by

OTTAWA, ONTARIO–(Marketwired – Feb 16, 2017) – PhytoPain Pharma Inc. (PPP), a subsidiary of Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that the Therapeutic Products Directorate (TPD) of Health Canada has approved its Phase […]

by

February 16, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, releases its 5th excerpt of its cannabis /hemp stock directory for investors following the sector and provides commentary from Technavio on four key drivers for the industry. Technavio http://www.technavio.com/ analysts forecast the global legal marijuana market to […]

by